A
Aleksander Prejbisz
Researcher at Dresden University of Technology
Publications - 263
Citations - 5771
Aleksander Prejbisz is an academic researcher from Dresden University of Technology. The author has contributed to research in topics: Medicine & Blood pressure. The author has an hindex of 32, co-authored 231 publications receiving 4168 citations. Previous affiliations of Aleksander Prejbisz include University of Wrocław.
Papers
More filters
Journal ArticleDOI
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
Tracy Ann Williams,Tracy Ann Williams,Jacques W.M. Lenders,Jacques W.M. Lenders,Paolo Mulatero,Jacopo Burrello,Marietta Rottenkolber,Christian Adolf,Fumitoshi Satoh,Laurence Amar,Marcus Quinkler,Jaap Deinum,Felix Beuschlein,Kanako Kiriyama Kitamoto,Uyen Thi Phuong Pham,Ryo Morimoto,Hironobu Umakoshi,Aleksander Prejbisz,Tomaz Kocjan,Mitsuhide Naruse,Michael Stowasser,Tetsuo Nishikawa,William F. Young,Celso E. Gomez-Sanchez,John W. Funder,Martin Reincke +25 more
TL;DR: Consensus was reached for criteria for six outcomes based on blood pressure, use of antihypertensive drugs, plasma potassium and aldosterone concentrations, and plasma renin concentrations or activities based on clinical and biochemical outcomes.
Journal ArticleDOI
Effects of Renal Sympathetic Denervation on Blood Pressure, Sleep Apnea Course, and Glycemic Control in Patients With Resistant Hypertension and Sleep Apnea
Adam Witkowski,Aleksander Prejbisz,Elżbieta Florczak,Jacek Kądziela,Paweł Śliwiński,Przemyslaw Bielen,Ilona Michałowska,Marek Kabat,E. Warchol,Magdalena Januszewicz,Krzysztof Narkiewicz,Virend K. Somers,Paul A. Sobotka,Andrzej Januszewicz +13 more
TL;DR: Catheter-based renal sympathetic denervation lowered BP in patients with refractory hypertension and obstructiveSleep apnea, which was accompanied by improvement of sleep apnea severity, and Interestingly, there are also accompanying improvements in glucose tolerance.
Journal ArticleDOI
Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19.
Reinhold Kreutz,Engi Abd El-Hady Algharably,Michel Azizi,Piotr Dobrowolski,Tomasz J. Guzik,Andrzej Januszewicz,Alexandre Persu,Aleksander Prejbisz,Thomas Günther Riemer,Ji-Guang Wang,Michel Burnier +10 more
TL;DR: A critical review of available evidence does not support a deleterious effect of RAS blockers in COVID-19 infections, and therefore, there is currently no reason to discontinue Ras blockers in stable patients facing the CO VID-19 pandemic.
Journal ArticleDOI
Cardiovascular manifestations of phaeochromocytoma
TL;DR: As the cardiovascular complications of phaeochromocytoma can be life-threatening, all patients who present with manifestations that even remotely suggest excessive catecholamine secretion should be screened for the disease.
Journal ArticleDOI
Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial
Tanja Dekkers,Aleksander Prejbisz,Leo J. Schultze Kool,Hans Groenewoud,Marieke Velema,Wilko Spiering,Sylwia Kołodziejczyk-Kruk,Mark J. Arntz,Jacek Kądziela,Johannes F Langenhuijsen,Michiel N. Kerstens,Anton H. van den Meiracker,Bert-Jan H. van den Born,Fred C.G.J. Sweep,Ad R. M. M. Hermus,Andrzej Januszewicz,Alike F Ligthart-Naber,Peter Makai,Gert Jan van der Wilt,Jacques W.M. Lenders,Jacques W.M. Lenders,Jaap Deinum +21 more
TL;DR: A non-significant mean difference of 0·05 (95% CI -0·04 to 0·13) in quality-adjusted life-years (QALYs) was found to the advantage of the AVS group, associated with a significant increase in mean health-care costs of €2285 per patient.